Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
Latest News
Reminder that COVID-19 and cancer can be a deadly combo
Publish date:
October 20, 2022
FROM JMIR CANCER
A version of this article first appeared on
Medscape.com
.
Pages
« first
1
2
Recommended Reading
CDC: Masking no longer required in health care settings
MDedge Hematology and Oncology
Evusheld PrEP may protect immunocompromised patients from severe COVID-19
MDedge Hematology and Oncology
Three COVID scenarios that could spell trouble for the fall
MDedge Hematology and Oncology
Epidemic of brain fog? Long COVID’s effects worry experts
MDedge Hematology and Oncology
Why people lie about COVID
MDedge Hematology and Oncology
For many, long COVID’s impacts go on and on, major study says
MDedge Hematology and Oncology
The marked contrast in pandemic outcomes between Japan and the United States
MDedge Hematology and Oncology
New deep dive into Paxlovid interactions with CVD meds
MDedge Hematology and Oncology
You and the skeptical patient: Who’s the doctor here?
MDedge Hematology and Oncology
New COVID variant gaining traction in U.S.
MDedge Hematology and Oncology
COVID-19 Updates
Patient & Survivor Care
Melanoma
Breast Cancer
All Specialties
